News 29 jan 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 04 abr 2024 Indivi joins forces with Biogen Indivi and Biogen are cooperating on the development of digital biomarkers for Parkinson’s disease. To this end, the US biotech group is licensin...
News 27 mar 2024 TissueLabs begins biofabrication activities in Bellinzona TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh ...
Aktuell 04 abr 2024 Indivi spannt mit Biogen zusammen Indivi und Biogen wollen bei der Entwicklung digitaler Biomarker für die Parkinson-Krankheit kooperieren. Dafür lizenziert der amerikanische Biot...
News 26 mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Aktuell 27 mar 2024 TissueLabs startet Biofabrikation in Bellinzona TissueLabs sichert sich 800'000 Dollar und eröffnet ein neues Zentrum für Biofabrikation in Bellinzona. Die Mittel dienen der Verbesserung der ei...
News 03 abr 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
Aktuell 03 abr 2024 Nouscom erhält weitere Mittel für Krebsimpfstoffe Nouscom hat eine Investition in der Höhe von 7 Millionen Euro von der italienischen Risikokapitalfirma Angelini Ventures erhalten. Damit kann das...
Member of the Month 03 fev 2023 BROMATECH Suisse SA: "S-GE helps us better understand sales markets as well as the distribution channels" BROMATECH Switzerland is active in the development of dietary supplements based on lactic acid bacteria capable of interacting in a targeted and ...
News 26 jan 2023 Bionomous secures USD 2.7 million to automate life science research Bionomous, a start-up based in the canton of Fribourg, raised USD 2.7 Million for its first CE-marked device which helps automate life science re...
Mitglied des Monats 03 fev 2023 BROMATECH Suisse SA: "S-GE hilft uns, die Absatzmärkte sowie die Vertriebskanäle besser zu verstehen" BROMATECH Schweiz ist in der Entwicklung von Nahrungsergänzungsmitteln auf der Basis von Milchsäurebakterien tätig, die in der Lage sind, gezielt...
News 29 fev 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 05 mar 2024 Immunocore turns to Oncobit platform The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the U...
Actualités 17 abr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 26 jan 2023 Bionomous lève USD 2,7 millions pour automatiser la recherche en sciences de la vie Bionomous a levé USD 2,7 millions pour son premier dispositif marqué CE qui aide à automatiser les processus de recherche en sciences de la vie.
Affiliato del mese 03 fev 2023 Bromatech SUISSE (SA) : “S-GE ci aiuta a comprendere meglio i mercati di vendita e i canali di distribuzione”. Bromatech Suisse si occupa dello sviluppo di integratori alimentari naturali a base di batteri acidolattici in grado di interagire in modo mirato...